Impact Factor
4.75
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
14.50
3,947 total citations
h5-index
94
h5 depth signal
Cited share
87.8%
252 of 287
Total citations
3,947
Citation footprint
Metric signal
14.61
External metric anchor
Self-citation
0.3%
11 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
597
China
269
Germany
130
United Kingdom
130
Italy
101
Citing Fields of Research
Immunology
268
Oncology
190
Cancer & Development
141
Cardiology
134
Cellular Membrane Transporters & Receptors
127
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,951
Articles tracked across the journal lifetime
Indexed publication set
287
252 cited publications
Last 12 months
107
8.9 publications/month
Open access share
24.3%
26 OA publications in the last year
Leading citing country
United States
597 citing publications
Leading citing field
Immunology
268 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v4n1, 1979-
v4n1, 1979-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cellular Membrane Transporters & Receptors
Immunology
Cardiology
Neurodegenerative Disorders
Cancer, Autophagy & Apoptosis
Oncology
Diabetes
Broad Categories
Drug Therapy
Pharmacology
Therapeutics
Molecular & Cellular Toxicology
Cellular Membrane Transporters & Receptors
Cancer, Autophagy & Apoptosis
Immunology
Genetics & Genomics
Neurodegenerative Disorders
Lipids
MeSH Descriptors
Pharmacology
Therapeutics
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.pharmthera.2026.109132
Open DOI
Prospects for adiponectin-based therapeutics in myocardial ischemia reperfusion injury
02
DOI 10.1016/j.pharmthera.2026.109130
Open DOI
Mitochondrial dysfunction in Alzheimer’s disease: mechanisms, pathogenic interplay, and therapeutic opportunities
03
DOI 10.1016/j.pharmthera.2026.109131
Open DOI
Sinoatrial node dysfunction: molecular mechanisms, arrhythmogenesis, and translational pathways toward precision therapy
04
DOI 10.1016/j.pharmthera.2026.109129
Open DOI
Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap
05
DOI 10.1016/j.pharmthera.2026.109127
Open DOI
The rhythm of pressure: Circadian disruption and chronotherapy
06
DOI 10.1016/j.pharmthera.2026.109128
Open DOI
The regulatory and therapeutic potential of transposable elements in cancer and inflammatory diseases
07
DOI 10.1016/j.pharmthera.2026.109126
Open DOI
Drug resistance in cancer: Emerging mechanisms, translational barriers, and pharmacological strategies
08
DOI 10.1016/j.pharmthera.2026.109125
Open DOI
Galectin-3 and its inhibitors: Overview and perspectives
09
10
DOI 10.1016/j.pharmthera.2026.109120
Open DOI
B-cell precursor acute lymphoblastic leukaemia: origins, classification, and therapeutic advances
Bibliographical & Catalog Notes
Journal of the International encyclopedia of pharmacology and therapeutics.
Also available online.
Formed by the union of Pharmacology & therapeutics. Part A: Chemotherapy, toxicology and metabolic inhibitors, of Pharmacology & therapeutics. Part B: General & systematic pharmacology, and of Pharmacology & therapeutics. Part C: Clinical pharmacology and therapeutics.
Vol. 44, no. 1 (1989)19920909 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper